Disclaimer: This information is provided for the use of physicians and other licensed health care practitioners only. This information is not for use by consumers. The information and or products are not intended for use by consumers or physicians as a means to cure, treat, prevent, diagnose or mitigate any disease or other medical condition. The information contained in this document is in no way to be taken as prescriptive nor to replace the physicians duty of care and personalised care practices.
Dr. Zava, ZRT Founder & Chief Scientist, and Dr. Placzek, ZRT Senior Research Scientist, discuss the clinical utility of urinary neurotransmitter testing in the context of addressing and managing neurochemical imbalances pertaining to mood disorders.
In this one hour webinar, they cover the following topics:
- Introduce neurotransmitter testing as a complementary addition to hormone testing - outlining its use in providing more information regarding a patient’s individual biochemical heterogeneity
- Discuss the etiology of mood disorders, and illustrate how excessive or deficient levels of certain neurotransmitters in both the brain and in the periphery are associated with a spectrum of neurobiological disorders
- Explain how neurotransmitter testing can help achieve a diagnostic edge over traditional psychological inventory when addressing poor brain health
- Rationalise the dried urine approach as a simple, convenient, and effective collection method to assess neurotransmitter levels
Testing neurotransmitters in patients with psychological conditions can help target specific imbalances – getting to the root of persistent issues such as adrenal dysfunction, mood disorders, lack of ambition and lack of appetite.
CLICK TO FIND OUT MORE (Including profile details, prices and sample reports).
Dr. Placzek, ZRT Senior Research Scientist at ZRT Laboratory has written a selection of blogs highlighting the role of neurotransmitters: